Elanco Animal Health Incorporated

NYSE (USD): Elanco Animal Health Incorporated (ELAN)

Last Price

14.22

Today's Change

+0.09 (0.63%)

Day's Change

13.83 - 14.28

Trading Volume

3,978,492

Profile
ELAN

Exchange:  New York Stock Exchange New York Stock Exchange

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Jeffrey N. Simmons Mr. Jeffrey N. Simmons

Full Time Employees:  9,300 9,300

IPO Date:  2018-09-20 2018-09-20

CIK:  0001739104 0001739104

ISIN:  US28414H1032 US28414H1032

CUSIP:  28414H103 28414H103

Beta:  1.42 1.42

Last Dividend:  0.00 0.00

Dcf Diff:  22.16 22.16

Dcf:  -8.22 -8.22

Description

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Address

2500 Innovation Way,
Greenfield, IN 46140, US

877 352 6261

http://www.elanco.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment